cs.CVMar 24, 2026

Retinal Disease Classification from Fundus Images using CNN Transfer Learning

Authors: Ali Akram

Organizations: CliftonLarsonAllen (CLA)

Abstract

Retinal diseases remain among the leading preventable causes of visual impairment worldwide. Automated screening based on fundus image analysis has the potential to expand access to early detection, particularly in underserved populations. This paper presents a reproducible deep learning pipeline for binary retinal disease risk classification from publicly available fundus photographs. We implement and compare a baseline convolutional neural network with a transfer learning approach using a pretrained VGG16 backbone and evaluate generalization on held-out data. To address class imbalance, we apply class weighting and report standard classification metrics including accuracy, precision, recall, F1-score, confusion matrices, and ROC-AUC. The VGG16 transfer learning model achieves 90.8% test accuracy with a weighted F1-score of 0.90, substantially outperforming the baseline CNN (83.1% accuracy). Results indicate that transfer learning improves discrimination compared to a baseline CNN, while also revealing remaining challenges in sensitivity to minority disease cases. We discuss practical limitations related to dataset characteristics, class imbalance, and threshold selection, and provide guidance for reproducibility and future improvements for clinically reliable screening

Explore similar work

May 12, 2024

Explainable Convolutional Neural Networks for Retinal Fundus Classification and Cutting-Edge Segmentation Models for Retinal Blood Vessels from Fundus Images

Early detection of vision-threatening conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration depends on retinal fundus image analysis, but manual assessment is slow and expert-dependent. Automated convolutional neural networks classify fundus images accurately yet act as black boxes, and existing retinal vessel segmentation methods lose discriminative power under pathology and seldom exploit attention or transformer backbones. Using the FIVES and DRIVE fundus datasets, we develop a two-pipeline framework that pairs four-class disease classification with attention- and transformer-based vessel segmentation, organised in three stages: (1) FIVES images are augmented by rotation and horizontal and vertical flips and used to fine-tune eight ImageNet-pretrained CNNs: ResNet101, DenseNet169, Xception, InceptionV3, DenseNet121, InceptionResNetV2, ResNet50, and EfficientNetB0. (2) Five gradient-based explanation methods, Grad-CAM, Grad-CAM++, Score-CAM, Faster Score-CAM, and Layer-CAM, are computed on the final convolutional block of each classifier and compared qualitatively across architectures. (3) Ten U-Net variants are benchmarked for vessel segmentation: TransUNet (hybrid CNN--Transformer encoder) and Attention U-Net (gated skip connections), evaluated with ResNet50V2, ResNet101V2, and ResNet152V2 backbones, along with additional Attention U-Net configurations using DenseNet backbones, and the fully transformer-based Swin-UNet. ResNet101 gives the highest classification accuracy: 94.17% (F1 0.942) >> 88.33% for EfficientNetB0. For segmentation, the architecture ranking is consistent on both datasets: Attention U-Net >> TransUNet >> Swin-UNet. The strongest configuration is Attention U-Net with a ResNet101V2 backbone: FIVES IoU 0.722, Dice 0.838; DRIVE IoU 0.648, Dice 0.787, lifting DRIVE IoU 60.80 →\rightarrow 64.83 over a prior custom U-Net.
May 25, 2026

Benchmarking Convolutional, Transformer, Hybrid, and Vision Language Models for Multi Disease Retinal Screening

Modern deep learning offers powerful tools for automated retinal screening, but it remains unclear how different visual model families compare in realistic multi-disease settings and under domain shift. In this work, we benchmark twelve architectures across four model families: convolutional neural networks, vision transformers, hybrid CNN-transformer backbones, and vision-language models, using the Retinal Fundus Multi-disease Image Dataset (RFMiD). We evaluate two tasks: binary screening for any retinal disease and multi-label classification across 28 disease classes. Using standardized training, calibration, and evaluation protocols, we report AUC, F1, precision, recall, and sensitivity at a clinically relevant operating point with specificity near 80%. On RFMiD, all architectures perform well on binary screening, with AUC above 84%, but attention-based models perform best. SwinTiny and the hybrid CoAtNet0 and MaxViTTiny models achieve the strongest binary screening results and improve macro and micro F1 in the multi-label setting. Vision-language models, including CLIP ViT-B/16 and SigLIP-Base384, are competitive with CNN baselines but do not surpass the best transformer and hybrid backbones. In external validation on Messidor-2 for referable diabetic retinopathy, AUC ranges from 66.8% to 84.7%, with hybrid and transformer models again showing strong performance. These results provide a reproducible reference for model selection in multi-disease retinal screening and guide future automated screening tools for clinical deployment.
Mar 12, 2026

Diabetic Retinopathy Grading with CLIP-based Ranking-Aware Adaptation:A Comparative Study on Fundus Image

Diabetic retinopathy (DR) is a leading cause of preventable blindness, and automated fundus image grading can play an important role in large-scale screening. In this work, we investigate three CLIP-based approaches for five-class DR severity grading: (1) a zero-shot baseline using prompt engineering, (2) a hybrid FCN-CLIP model augmented with CBAM attention, and (3) a ranking-aware prompting model that encodes the ordinal structure of DR progression. We train and evaluate on a combined dataset of APTOS 2019 and Messidor-2 (n=5,406), addressing class imbalance through resampling and class-specific optimal thresholding. Our experiments show that the ranking-aware model achieves the highest overall accuracy (93.42%, AUROC 0.9845) and strong recall on clinically critical severe cases, while the hybrid FCN-CLIP model (92.49%, AUROC 0.99) excels at detecting proliferative DR. Both substantially outperform the zero-shot baseline (55.17%, AUROC 0.75). We analyze the complementary strengths of each approach and discuss their practical implications for screening contexts.